Medicine and Dentistry
Asthma
100%
Disease
29%
Respiratory Disease
28%
Chronic Rhinosinusitis
25%
Chronic Obstructive Pulmonary Disease
20%
Allergen
20%
Nasal Polyp
20%
Biological Marker
17%
COVID-19
14%
Severe Asthma
13%
Biological Product
13%
Nitric Oxide
12%
Sputum
12%
Pathophysiology
11%
Clinical Trial
10%
Methacholine
10%
Symptom
10%
Personalized Medicine
9%
Mepolizumab
9%
Placebo
9%
Treatment Response
8%
Respiratory Tract Inflammation
8%
Endotype
8%
Pediatrics
7%
Allergic Asthma
7%
Patient-Reported Outcome
7%
Quality of Life
6%
Patient with Asthma
6%
Oscillometry
6%
Allergic Rhinitis
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Provocation Test
6%
Immunopharmacology
6%
PDE3 Inhibitor
6%
Respiratory Care
6%
Clinician
5%
Eosinophilic
5%
Drug Therapy
5%
Targeted Therapy
5%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
88%
Disease
25%
Respiratory Tract Disease
21%
Chronic Rhinosinusitis
15%
Nose Polyp
15%
Chronic Obstructive Lung Disease
13%
Placebo
12%
Allergen
11%
Biological Product
10%
Respiratory Tract Inflammation
10%
Pharmacokinetics
9%
Macrophage Elastase
9%
Tolerability
8%
Normal Human
8%
Clinical Trial
8%
Allergic Asthma
8%
Symptom
7%
Pathophysiology
7%
SARS Coronavirus
7%
Nitric Oxide
7%
Allergic Rhinitis
6%
Immunotherapy
6%
Allergic Reaction
6%
Methacholine
6%
Coronavirinae
6%
Pandemic
6%
Chronic Respiratory Tract Disease
6%
Phosphodiesterase III Inhibitor
6%
Immune System Pharmacology
6%
Fluticasone Propionate
6%
Mometasone Furoate
6%
Bronchoconstriction
6%
Indacaterol
6%
Glycopyrronium
6%
Biological Marker
5%
Adverse Event
5%
Provocation Test
5%
Respiratory Tract Allergy
5%
Keyphrases
Asthma
37%
Severe Asthma
9%
COVID-19
9%
EUFOREA
9%
Allergen
8%
Allergic Rhinitis
7%
Allergic Asthma
7%
Fractional Exhaled Nitric Oxide (FeNO)
6%
Precision Medicine
6%
Allergen Bronchoprovocation Test
6%
Asthma Treatment
6%
Comorbidity
5%
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
5%
